Industry Outlook

Hemostasis and tissue sealing agents are material used for restricting bleeding or hemorrhage caused from injuries or during surgical procedures. Perpetual innovation in the field of hemostasis, and increased volume of surgical procedures together drive the growth of this market. Growth in the prevalence of chronic diseases and geriatric population has led to increased number of surgeries performed worldwide. Conditions such as cardiovascular diseases, hernia, ophthalmic conditions, gynecological and urological conditions, and burns frequently require surgical intervention wherein hemostats and tissue sealants are required.

Hemostats and tissue sealing agents are used for prevention of blood loss and have wide application in surgical procedures. Minimally invasive surgical interventions are particular areas where hemostats are frequently used. Therefore, growing trend of adoption of minimally invasive surgeries promote the growth of hemostasis and tissue sealing agents market. However, lack of widespread and appropriate reimbursement to these products restrains the desired market growth.

Increasing Count of Surgical Procedures to Intensify the Market Growth

Based on the product types, the global hemostasis and tissue sealing agents market is categorized into hemostats, sealants and adhesives. The hemostats segment is further categorized as mechanical, active and flowable hemostats; sealants as fibrin and synthetic sealants; adhesives as Cyanoacrylate and, albumin and glutaraldehyde. Among these, hemostats segment enjoys the largest revenue share in the global market as these products offer greater cost efficiency, quick sealing properties and low tissue reactivity. Sealants and adhesives will witness rapid market growth during the forecast period on the ground of their proven efficiency in preventing blood loss from surgical sites in combination with other drugs. Growing demand of these products over surgical sutures is due to their faster application rate, less invasion, lower risk of infections and lesser exudate discharge. The market players engaged in production of hemostats and tissue sealing agents are engaged in production of novel agents that have wider applicability than the existing ones.  Furthermore, efforts are also being undertaken to bring innovation towards introducing natural sealants, which will have better bioavailability and therefore witness fast market growth.

North America and Asia Pacific to Remain the Most Prominent Regional Markets

At present, North America has largest revenue contribution in the global hemostasis and tissue sealing agents market. High prevalence of chronic diseases such as diabetes, and cancer in the region promote the dominance of North America market. Europe is estimated as the second largest regional market as the region witnesses swift approval to novel and technologically advanced products in the healthcare system, along with greater incidence of surgical procedures. Aggressive marketing of novel surgical products to surgeons also facilitates the dominance of Europe and North America on the global front. Additionally, Asia Pacific is anticipated to undergo the fastest market growth during the forecast period from 2018 to 2026. Favorable government policies and increasing healthcare expenditure, along with large potential patient pool contribute to the swift pace of Asia Pacific market. The burgeoning medical tourism industry in the region also supports the market growth in Asia Pacific.

The market dynamics in the hemostasis and tissue sealing agents industry are assessed for vivid understanding of the industry development. The dynamics for the global hemostasis and tissue sealing agents market are categorized into drivers, challenges, and opportunities. The report also includes competitive analysis of the prominent players in the global hemostasis and tissue sealing agents. The profiles of such players are also assessed in the study based on their business overview, product portfolio, financial information, and key developments. The prime players operating in the global hemostasis and tissue sealing agents market are Baxter International, Inc., Johnson & Johnson, CryoLife, Inc., Advanced Medical Solutions Group plc, Cohera Medical, Inc., Integra LifeSciences Corporation, Pfizer, Inc., C R Bard Inc., Cohesion Technologies, Inc., Zimmer Biomet, and B Braun Medical Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Hemostasis And Tissue Sealing Agents market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Hemostasis And Tissue Sealing Agents market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Hemostasis And Tissue Sealing Agents market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Hemostasis And Tissue Sealing Agents market?
• Which is the largest regional market for Hemostasis And Tissue Sealing Agents market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Hemostasis And Tissue Sealing Agents market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Hemostasis And Tissue Sealing Agents market worldwide?